In their Jan. 23, 2026 video discussion, Motley Fool contributors Jason Hall and Tyler Crowe highlight Albemarle’s leadership position, noting the company controls an estimated 20% of global lithium hydroxide capacity. With electric vehicle penetration projected to rise from 12% of new car sales in 2025 to 25% by 2030, industry forecasts from BloombergNEF foresee lithium demand growing at a compound annual rate exceeding 16% through 2030. Albemarle’s recently commissioned 50,000-metric-ton expansion in Australia, brought online in Q4 2025, is expected to add approximately $200 million in annualized EBITDA at current midcycle pricing, underpinning a robust long-term revenue trajectory. Investors are also buoyed by Albemarle’s integrated supply chain, which includes proprietary brine operations in Chile accounting for roughly 35% of its total output and insulating the company against spodumene concentrate cost swings.

Despite strong demand projections, the lithium sector remains cyclical, and Albemarle faces near-term headwinds from oversupply in the spodumene market. S&P Global data shows that global spot prices for battery-grade lithium carbonate have declined by nearly 30% from their March 2022 peak, pressuring downstream hydroxide margins. Moreover, ramp-up delays at the company’s joint venture in Quebec have pushed back first output by six months, deferring an anticipated $120 million in incremental EBITDA originally scheduled for H1 2026. Credit metrics also warrant caution: Albemarle’s net leverage ratio stood at 3.2x at the end of Q4 2025, near the upper end of its target range, leaving limited flexibility for additional capital spending or shareholder returns if market prices soften further.